Basic info
Industry
pharmaceuticals
Sectors
Medical Device
Biotechnology
Autism
Health Care
Alzheimer's Disease
Migraine
Schizophrenia
Delivery
Parkinson's Disease
Intranasal Drug Delivery
CNS Therapeutics
Date founded
2008
Funding rounds raised
Total raised
$68M
from 13 investors over 13 rounds
I
Impel NeuroPharma raised $50M on March 17, 2022
Investors: Oaktree Capital Management, L.P.
I
Impel NeuroPharma raised $50M on July 7, 2021
Investors: Oxford Finance LLC
I
Impel NeuroPharma raised $68M on December 6, 2018
Investors: Norwest Venture Partners, 5AM Ventures, KKR & Co. Inc., Vivo Capital and venBio Partners
I
Impel NeuroPharma raised $36M on December 2, 2016
Investors: venBio Partners, 5AM Ventures and Vivo Capital
I
Impel NeuroPharma raised $1.1M on August 29, 2016
Investors: Alliance of Angels
I
Impel NeuroPharma raised $2.6M on November 27, 2013
Investors: Alliance of Angels
I
Impel NeuroPharma raised $25K on August 10, 2012
Investors: Alliance of Angels